Hyperion Defi, Inc.
Pharmaceutical Preparations · Dallas, TX, United States
- PrincipalsDavid R. KnoxChief Financial Officerand 5 more
- CompanyHyperion Defi, Inc.Dallas, TX, United States
- Phone line+1 (833) 393-6684General business
Hyperion Defi, Inc. is an SEC-registered Nasdaq-listed company (ticker HYPD) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chair & board
Ellen R StrahlmanDirector (Board)
Happy David WaltersDirector (Board)
Michael S GeltzeilerDirector (Board)
Finance
David R. KnoxChief Financial Officer
Legal
Robert RubensteinGeneral Counsel
Everyone else on file (1)
Hyunsu JungOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Robert Rubenstein — General Counsel
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David R. Knox — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Hyunsu Jung — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Ellen R Strahlman — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capability